Metformine Zentiva K.S.

Metformin Hydrochloride, the active ingredient in Metformine Zentiva K.S., is a biguanide presented as an oral tablet for oral administration. It reduces hepatic glucose production and improves peripheral insulin sensitivity, providing long‑term glycaemic control for adults with type 2 diabetes mellitus.

GNH USA supplies Metformine Zentiva K.S. as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to EU GMP standards and offering reliable logistics for bulk and retail packaging.

Metformine Zentiva K.S. (metformin) is used in the management of disorders related to impaired glucose regulation.

- Type 2 diabetes mellitus: improves glycaemic control and lowers HbA1c levels. - Prediabetes (impaired fasting glucose): delays progression to type 2 diabetes when combined with lifestyle modification. - Polycystic ovary syndrome (off‑label): may improve insulin resistance and menstrual regularity.

Metformine Zentiva K.S. may cause a range of adverse reactions.

Common Side Effects: - Gastrointestinal upset: nausea, abdominal discomfort, or dyspepsia. - Diarrhea: frequent loose stools, especially during treatment initiation. - Metallic taste: transient alteration in taste perception. - Loss of appetite: reduced desire to eat. - Mild skin rash: occasional pruritic eruptions.

Serious or Rare Side Effects: - Lactic acidosis: a rare but potentially fatal accumulation of lactate. - Severe hypoglycaemia: usually when combined with insulin or secretagogues. - Vitamin B12 deficiency: may develop with long‑term use. - Hepatic dysfunction: abnormal liver enzymes or hepatitis. - Pancreatitis: inflammation of the pancreas. - Severe skin reactions: such as Stevens‑Johnson syndrome.

When prescribing Metformine Zentiva K.S., clinicians should consider several safety measures.

- Renal function assessment: avoid use in patients with severe renal impairment. - Hepatic function monitoring: caution in patients with liver disease. - Lactic acidosis risk: discontinue if signs of metabolic acidosis appear. - Elderly patients: start at lower doses and monitor tolerance. - Alcohol consumption: advise limiting intake to reduce acidosis risk. - Store at ambient temperature: keep below 25°C in the original packaging, protected from moisture.

Metformine Zentiva K.S. interacts with several medicines that may alter its efficacy or safety.

Major Interactions (Avoid): - Iodinated contrast agents: can precipitate acute renal failure and lactic acidosis. - Cimetidine: may increase metformin plasma concentrations. - Alcohol: potentiates risk of lactic acidosis.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycaemia symptoms. - ACE inhibitors or ARBs: can affect renal function, requiring dose adjustment. - Thiazide diuretics: may increase risk of hypoglycaemia.